Read Microsoft Word - 2.Syllabus PHR185P 2011 18 September2011.doc text version

PHR 185P Pharmacotherapeutics III Lab Syllabus

Executive Summary of the course and how it differs from the previous semester.

1. One week after the group receives the case(s), rotating student presenters will present the case to the members of the group and the facilitator. This case presentation will be in a SOAP-note type format. The time limit for this presentation is 12 minutes and will be strictly enforced (aim for 10 minutes). You each will receive an individual grade for your presentation. In addition, the group will receive a grade based on the average of the individual presentations. For the sake of constructive critique and your improvement, we will video record these presentations each week for you to review. In addition, your classmates will complete a critique of your performance (not graded). 2. You will be required to review the video recording in the week following your presentation, and write a short critique of your work. This critique will turned into your TA one week after the presentation. 3. An example of what we expect for your oral presentation will be given to you at the lab orientation session The first week of presentations will be practice sessions where random students will be called upon to present sections of the case. A trial Q&A session will also be conducted. 4. After each case presentation, there will be a Q&A period. The student who presented will be expected to answer questions about the case that will include the latest drug- and therapy-related information about the case topic. If the presenter cannot answer these questions the members of the group may provide assistance. Any questions that cannot be satisfactorily answered by the presenter or the group will become learning points, which will be answered as a separate report submitted the following week. 5. As part of the Q&A period, each member of the group, excluding that week's presenter(s), will be asked at least one individual question. These questions will relate to the cases presented. You will each receive a grade based on your response. An outline of the type of questions you should expect is included in the syllabus. 6. On two occasions during the semester, each student will have the opportunity to assess and grade the members of their group with regard to their participation in the lab. This grade will be included in the overall semester grade. 7. During the first portion of the course, there will be one case per week and one student will present. This will be followed by 2 hours to "work up" the next case as a group with the facilitator present. During the final weeks of the course, multiple cases will be presented each week. These cases will be "worked up" outside of lab. By using these two different approaches students will gain experience in group work, individual work and have two opportunities to present cases. First Portion

1st hour Present Case & extensive Q & A 2nd and 3rd hour Prepare next case

Second Portion

Present Case 1

Present Case 2

Present Case 3 3

Present Case 4

Present Case 5

The Bottom Line: Each week you will have to prepare case presentations and research a range of questions relating to the topics to be presented. Your group must learn to work effectively as a group to complete these assignments.

1

PHR 185P Pharmacotherapeutics III Lab Syllabus Course Description:

This is a problem-based laboratory that integrates the pathology, medicinal chemistry, pharmacology, and therapeutic aspects of various diseases in order to prepare students to make sound therapeutic decisions.

Prerequisites: The successful completion of the second professional year in the College of

Pharmacy and credit or registration for Pharmacy 695F and 395G are prerequisites.

Objectives of the Course:

1. To illustrate real-life cases seen in the practice of Pharmacy, and to practice solving basic pharmaceutical problems; 2. To stimulate the processes of group discussion, teamwork, and synergy in finding answers to basic and clinical questions arising from case study; 3. To continue to use the process of group-based problem solving for basic and therapeutic questions arising from structured case situations; 4. To aid students' independent problem-solving abilities through learning how to find and use existing resources with a particular emphasis on the use of current literature; 5. To stimulate long-term learning of pharmaceutical information that may or may not be covered in the didactic pharmacotherapeutics courses; 6. To learn to give effective patient presentations; and 7. To learn to answer questions in an effective, and professional style.

Course Coordinator:

J. Nile Barnes, PHR 2.222, 512-232-3494, [email protected] Office hours by appointment. Schedule an appointment: https://tungle.me/jnilebarnes

Local Coordinators:

Region Austin Edinburg El Paso San Antonio Coordinator Theresa Gerst, PharmD Yasar Tasnif, PharmD Selina Aguilar, PharmD Chris Martin, PharmD, MS Office PHR 2.222 E-RAHC 1.100.14 CHS 703 MCD 3.416 Phone 512-232-0828 956-665-7421 915-747-8302 210-567-3865 Email [email protected] [email protected] [email protected] [email protected] Office Hours TBA TBA TBA TBA

2

PHR 185P Pharmacotherapeutics III Lab Syllabus Teaching Assistants:

TA Natasha Shcherbakova AUSTIN Sections Tatiana Makhinova ELP, SAN & VAL Sections Office PHR 2.209 PHR 2.209 Phone Email [email protected] [email protected] Office Hours TBA TBA

512-471-8509

Textbooks and Materials:

The required text for this course is: Schwinghammer, T.L., Pharmacotherapy Casebook - A Patient-Focused Approach, 7th Edition, McGraw-Hill, New York, 2009. Also available on www.AccessPharmacy.com. Optional, but very useful: · Mary Lee, Interpreting Laboratory Data, 4th Edition (2009). ASHP; list $79.00; Amazon.com $64.91 · Stedman's Medical Dictionary for the Health Professions and Nursing, 5th ed., Lippincott, Williams and Wilkins (2005); or other Medical Dictionary. Amazon.com $39.35; free on Library web site · Washington University School of Medicine Department of Medicine, The Washington Manual of Medical Therapeutics, 33nd ed. (spiral bound-2010). Amazon.com $53; Students should NOT buy both this and Pocket Medicine. · Marc S. Sabatine, Pocket Medicine, 4rd ed. (ring bound-2010), Amazon.com $53; Students should NOT buy both this and the Washington Manual. · Neil M. Davis, Medical Abbreviations: 30,000 Conveniences at the Expense of Communications and Safety, 14th ed. (Paperback ­ November, 2008), Amazon.com $26.05 · Charles F. Lacy et al., Lexi-Comp's Drug Information Handbook, 19th ed. 2011, (Paperback), Amazon.com $43.99; free on Library web site · Karen J Tietze, Clinical Skills for Pharmacists, 2nd ed. (2004) Amazon.com $43.41; on Reserve in the LRC. · Richard Maxwell, Maxwell Quick Medical Reference, 5th ed. (2006) Amazon.com $7.95 · The Sanford Guide to Antimicrobial Therapy 2011 (41th edition). Sanfordguide.com or Amazon.com$15.95. An additional reference site which provides useful information on patient assessments and presentations is: http://meded.ucsd.edu/clinicalmed/oral.htm

3

PHR 185P Pharmacotherapeutics III Lab Syllabus

Course Times: Lab sessions meet for three hours according to the official course registration listings summarized below.

Unique number 59850 59855 59860 59865 Campus ELP ELP SAN SAN Day Tuesday Tuesday Tuesday Tuesday Hour 3:30-6:30 3:30-6:30 Room MCD 3.348 MCD 3.544 Facilitator Kreys, Duhon, Cabellero, & Xiao Labreche, Ramirez, Radosevich,& Sohraby Smith Lee Tasnif & Guerra Lestico & Jokerst Garrett & Anderson Luu & Ngo Gerst & Snyder Rush & Novak McIntyre & Barnes Wilson & Wilcox Danysh & Pan

59870 59875 59880 59885 59890 59905 59910 59895 59900 59915 59920

SAN SAN VAL AUS AUS AUS AUS AUS AUS AUS AUS

Thursday Thursday Wednesday Tuesday Tuesday Wednesday Wednesday Thursday Thursday Friday Friday

3:30-6:30 3:30-6:30 1:30-4:40 1:30-4:30 1:30-4:30 1:00-4:00 1:00-4:00 1:30-4:30 1:30-4:30 1:00-4:00 1:00-4:00

MCD 3.348 MCD 3.544 E-RAHC 1.204 PHR 3.114A PHR 3.114B PHR 3.114A PHR 3.114B PHR 3.114A PHR 3.114B PHR 3.114A PHR 3.114B

Course Details: 1. Group-facilitated discussion has been proven to be an aid in learning for students in the health professions. These laboratories are designed to facilitate the process of team building by making the basic knowledge taught in the Pharmacotherapeutics courses I, II, III, and IV "come alive" in structured case studies. Thus, the didactic lecture material will be expanded, reinforced, and made practical by the case-based learning method. NB: The Pharmacotherapy Laboratory is a separate course from the didactic Pharmacotherapeutics courses. It is not the purpose of the labs to help students prepare for examinations in the Pharmacotherapeutics courses. Although cases are scheduled after didactic lectures, it is

4

PHR 185P Pharmacotherapeutics III Lab Syllabus

not always possible to schedule the cases so that they will precede an exam in the pharmacotherapy courses. Likewise, it is probable that cases will cover material covered in previous semesters, whereupon students are encouraged to check current guidelines and literature to aid in understanding laboratory cases. This is especially true when cases depict multiple therapeutic problems. 2. There may be no facilitator present for the "working up" portion of the lab after the first few weeks. You will be expected to work as a group in preparing the cases. It is suggested that a student "team leader" be assigned on a rotating basis. It is the responsibility of the team leader to pass the attendance sheet, to encourage discussion, and to keep the discussion on track. It will not be the student leader's responsibility to lecture, to correct erroneous information, and to make sure that everyone participates. Students are expected to participate on their own initiative. The facilitator will be there for you to present cases and ask questions regarding the case. During the last two weeks the cases will not be group cases but individual cases. No class time will be available to "work up" the cases. 3. Attendance is mandatory in this course. Attendance will be taken at the beginning of every session. No unexcused absences are permitted. Excused absences are only accepted in the case of an emergency, illness, or College function approved by the Dean. In all cases the student should attempt to contact the Course Coordinator before missing a lab. There will be a lowering of one letter grade in the course for each unexcused absence in the course. Making up material covered in a session is the student's responsibility, though under special circumstances, this may be negotiated with the Course Coordinator. Students should attempt to attend their regularly scheduled laboratory at all times. Switching to another lab section will only be permitted when there is a valid excuse. Switching laboratories produces a hardship on the facilitators, other students, and T.A.s who are attempting to keep track of lab reports and grades. Permission to switch lab must be obtained in advance from the course coordinator: Dr. Barnes: [email protected] If you are attending a professional state or national meeting that conflicts with your lab day, you must contact the course coordinator and lead TA at least two weeks before the meeting to make arrangements for a makeup lab. For all other absences, please contact the course coordinator and lead TA as soon as you know you will need to schedule a makeup lab. 4. The laboratory will be graded using the following criteria: Average of your Individual presentations (2 cases averaged): (Presentation skills 40%) (Clinical skills 40%) (Question response 10%) (Professionalism 10%) Average of the individual presentations for your group for the semester: Average of your group's weekly question & answer grades for the semester Average of your individual weekly question & answer grades for the semester: Average of your peer-reviewed assessments for the semester: Total semester points for each student: 40 points

30 points 10 points 10 points 10 points 100 points 5

PHR 185P Pharmacotherapeutics III Lab Syllabus

The following grading scale will be used: 92-100 85-91 75-84 65-74 Below 65 A B C D F This scale may be adjusted downward (i.e., greater ranges for A, B, etc.), but not upward, at the discretion of the Course Coordinator.

5. The only material allowed for your oral SOAP presentation is the one page (2-sided) clinical note form (scut sheet). With the exception of your lab manual, no additional reference material (including texts, personal computers and PDAs) may be brought to the presentation session. You may include as little or as much information on this clinical note as you choose. Please note though, that this sheet is intended to be used strictly as a reference sheet, not as a life-support line! Three (3) copies of your clinical form must be given to the TA/Faculty at the beginning of your presentation. This clinical note will NOT be graded. It will however be inspected to ensure that you have not written out your presentation verbatim. The one page clinical note should be handwritten, typed pages will not be allowed to be used during the presentation. 6. The maximum time limit for the SOAP presentation is 12 minutes. This will be strictly enforced. Two points will be deducted from your presentation grade for each minute you go over this time limit. Presentations that are unduly short (<8 minutes) may also be penalized. As a rule of thumb, you should aim to spend less than 50% of your time presenting the subjective and objective information for the case and devote the majority of the time to the assessment and plan The key to success in this area is PRACTICE. You will not accidentally arrive at a time of 10-12 minutes. Practice your presentation aloud in front of the mirror, to your peers or any willing audience you can locate. 7. The questions asked during the Q&A period of your presentation will come from your facilitator(s). They may cover multiple current topics such as information about the primary disease state and associated disease states. In addition, you should be very familiar with the current pharmacologic assessment, and all aspects of the drug plan, including possible drug interactions and side effects of the medications. The presenter should also be prepared to explain any of the technical terms presented in the case. 8. The facilitator will grade the oral presentation each week. A copy of the criteria will be placed on Blackboard for you to review. Grades will be posted online in the blackboard during the week following your lab. An electronic of your critique will be returned to you the week after your individual presentation. 9. Each person in the group will have the opportunity to present two cases. Your group should make a schedule of presenters on the first day of lab and give this schedule to your TA and facilitator. 10. You will be required to view your video in the week following your presentation and turn in a brief written critique of your work. The critique form is included in Blackboard.

6

PHR 185P Pharmacotherapeutics III Lab Syllabus

11. The video will be posted to your Blackboard section. This critique and the recording must be turned into the TA electronically within one week. Failure to critique yourself will result in a 10% penalty from your Presentation grades. This video recording is private; it may not be shared with anyone or posted for outside viewing. Each student will sign a copy of the honor code when viewing the video recording. Sharing the video recording is considered academic dishonesty. 12. Because almost a third of the final grade is based on the average of the individual presentations for the group, it is imperative that all team members help the group leader in preparing for his/her presentation as well as answering the questions during the Q&A period. The average group grade will be posted into the Blackboard at three-weekly intervals to maintain individual grade anonymity. 13. A Q&A session for the group members not presenting that week will follow each presentation. Each student will be asked at least one question. You will be graded out of a possible 10 points in accordance with the criteria below. · · Students who correctly answer their individual question or who provide a partially correct answer will receive a maximum of 7/7 points for section A. Students who fail to answer their question, or give an incorrect response can gain partial credit (a maximum of 3/7) if they can correctly identify the best information source that could be used to answer the question. Section B assesses the style of question answering and professionalism. A maximum of 3 points may be assigned to students who respond in a clear, concise, authoritative and professional manner. Additionally, violation of dress code policy may result in a loss of all points for Section B.

·

A sample grade sheet is included on Blackboard. Grades will be posted in Blackboard each week. The average of these weekly grades will account for 10 percent of the overall semester grade. The questions posed in this section will be pharmacy / drug related questions based on the medications prescribed or referred to in your case for that week. An outline of these types of questions posted on Blackboard. It is strongly recommended that you work as a team to prepare the answers for these questions. 14. To encourage each student to contribute to their team effort, there will be two scheduled peer evaluations in the semester where each student gets the opportunity to grade their group members. Students will receive the average of the individual grades assigned by their peers which will be posted on the e-grade book in the week subsequent to the evaluation week. This component of the course will account for 10 percent of your final grade. 15. The first week of presentations will be a practice week. Students will be called upon at random to present sections of the case. A practice Q&A session will also be conducted. While this lab will not be graded, it is in your interest to prepare and participate fully.

7

PHR 185P Pharmacotherapeutics III Lab Syllabus

16. There will be mid- and end-of-semester surveys where you evaluate the faculty facilitators, T.A.s and course. All students are strongly encouraged to fill out these evaluations, as an aid to improving the course Practice in Professionalism. As a pharmacist, you are expected by your patients, subordinates, employers, and colleagues, to dress in a professional manner. Professional dress needs to be appropriate to the clinical environment. Patient's expectations for professional dress differ depending upon the setting where they receive their care. In general, for a pharmacist in most clinical settings, professional dress means a clean, white lab coat with your name clearly identified. In any setting, the pharmacist should always be clean, well kept, and present a professional image. Dress Code for Pharmacotherapy Labs: Clean, white lab jacket with your name clearly identified Men: full length slacks, dress shirt or polo shirt Women: pants or skirts with blouses or dresses No shorts (pant length must remain below the knee at all times) No denim clothing or jeans of any color No backless or muscle shirts No athletic shoes No flip-flops Not all possibilities can be included in any set of rules. Inappropriate dress, based on the above criteria, may result in a warning, dismissal from the lab, no credit for that day's work, or a grade reduction. If there is any doubt, as to the correct dress for that laboratory setting, do not wear the item without asking first. University Honor Code The core values of The University of Texas at Austin are learning, discovery, freedom, leadership, individual opportunity, and responsibility. Each member of the university is expected to uphold these values through integrity, honest, trust, fairness, and respect towards peers and community. College of Pharmacy's Statement on Scholastic Dishonesty: "Pharmacy practitioners enjoy a special trust and authority based upon the profession's commitment to a code of ethical behavior in its management of client affairs. The inculcation of a sense of responsible professional behavior is a critical component of professional education, and high standards of ethical conduct are expected of pharmacy students. Students who violate University rules on scholastic dishonesty are subject to disciplinary penalties, including failure of the course involved and dismissal from the college and/or the University. Since dishonesty harms the individual, fellow students, and the integrity of the University and the College of pharmacy, policies of scholastic dishonesty will be strictly enforced in this class". Religious Holy Days By UT Austin policy, you must notify the course coordinator of your absence at least fourteen days prior to the date of a religious holy day. If you must miss a class, an examination, a work

8

PHR 185P Pharmacotherapeutics III Lab Syllabus

assignment or project in order to observe a religious holy day, you will be given an opportunity to complete the missed work within a reasonable time. Behavioral Concerns Advice Line (BCAL) If you are worried about someone who is acting differently, you may use the Behavioral Concerns Advice Line to discuss by phone your concerns about another individual's behavior. This service is provided through a partnership among the Office of the Dean of Students, the Counseling and Mental Health Center, the Employee Assistance Program and The University of Texas Police Department. Call 512-232-5050 or www.utexas.edu/safety/bcal Documented Disability Statement "Students with disabilities may request appropriate academic accommodations from the Division of Diversity and Community Engagement, Services for Students with Disabilities at 471-6259 (voice) or 232-2937 (video phone) or www.utexas.edu/diversity/ddce/ssd. Please contact the course coordinator regarding disability accommodations as soon as possible. These cannot be retroactive and must be approved by Services for Students with Disabilities. WHAT IS PLAGIARISM? Students who violate University rules on scholastic dishonesty are subject to disciplinary penalties, including failure of the course and dismissal from the University. Policies of scholastic dishonesty are strictly enforced. (This laboratory is governed by the Honor Code of the College and the University) As is always the case for such things, this document arose following certain incidents occurring in a previous year's lab. For reasonable, professional people, operating under an honor code, such carefully drawn, legalistic definitions may not be necessary; however, prudence is the better part of valor. According to the dictionary: "Plagiarize: To steal and use (the ideas or writings of another) as one's own. Or: To appropriate passages or ideas from (another) and use them as one's own. Or: To take and use as one's own the writings or ideas of another." Prohibited activities: a. Using the work of others students that has been done earlier in the week including viewing video recordings b. Using the work of other students done in the previous semesters.

Note: Plagiarism, as indicated in the course syllabus, is a major form of scholastic dishonesty. Each student must decide whether failing the course or being dismissed from the College is worth the risk involved in plagiarism.

9

PHR 185P Pharmacotherapeutics III Lab Syllabus

Lab Facilitators

Austin Groups | Local Coordinator Theresa Gerst Lab Day Facilitators* email Unique Tuesday Mitch Lestico & [email protected] 59885 Jason Jokerst [email protected] Tuesday Stephanie Garrett & [email protected] 59890 Megan Anderson [email protected] Wednesday Cindy Luu & [email protected] 59905 Jenny Ngo [email protected] Wednesday Theresa Gerst & [email protected] 59910 Morgan Snyder [email protected] Thursday Sharon Rush & [email protected] 59895 Suzanne Novak [email protected] Thursday Nile Barnes & [email protected] 59900 Bill McIntyre [email protected] Friday Jim Wilson & [email protected] 59915 Rich Wilcox [email protected] Friday Renee Danysh & [email protected] 59920 Neil Pan [email protected] San Antonio Groups | Local Coordinator Chris Martin Lab Day Facilitators* email Unique Tuesday Eugene Kreys, [email protected] 59860 Bryson Duhon, [email protected] Christina Cabellero, [email protected] Bin Xiao [email protected] Tuesday Matt Labreche [email protected] 59865 Debra Rameriz [email protected] Joelle Radosevich [email protected] Rose Sohraby [email protected] Thursday Amber Smith [email protected] 59870 Thursday Grace Lee [email protected] 59975 El Paso Groups | Local Coordinator Selina Aguilar Lab Day Facilitators* email Unique Tuesday Rotating Subject Matter Experts: 59850 This list will be provided to the El Paso Students Tuesday 59855 El Paso Group | Local Coordinator Yasar Tasnif Lab Day Facilitator* email Unique Wednesday Yasar Tasnif [email protected] 59880 Veronica Guerra [email protected]

10

PHR 185P Pharmacotherapeutics III Lab Syllabus Case Presentation Schedule Fall 2011

Date WEEK 0 Aug 30Sep 2 WEEK 1 Sept 6-9 WEEK 2 Sept 13-16 WEEK 3 Sept 20-23 WEEK 4 Sept 27-30 WEEK 5 Oct 4-7 WEEK 6 Oct 11-14 WEEK 7 Oct 18-21 WEEK 8 Oct 25-28 Case No presentation ­ introductory lab meeting with TA and facilitator, sign-up for case presentations, prepare for first presentation Community Acquired Pneumonia-Fever with a Cough* Cellulitis-A Case of Gripping Pain T2DM:New Diagnosis T1DM: DKA Peer Evaluation #1 Hypothyroidism Endocarditis Bipolar Disorder Case# Prepare Case 113

You must request an excused absence two weeks prior for official University or College functions!

Student Presenters XXXXXXXXXXXX

Present Case 113 117 79 78 82 119 74 72 34 73 75 114 118 123 83 67 41 28 29 101 61

No grade, everyone practices!

Schizophrenia Nausea and Vomitingf Peer Evaluation #2 WEEK 9 MDD Nov 1-4 GAD WEEK 10 Otitis media Nov 8-11 Diabetic Foot Infection Lower Urinary Tract Infection Cushing's Syndrome ADHD WEEK 11 Hepatic Encephalopathy Nov 15-18 GERD Peptic Ulcer Disease Drug Eruption Status Epilepticusf * Practice presentation / Q&A session f Only for groups with 10 students

Note: This case schedule may change throughout the semester to accommodate changes that may be made to the Pharmacotherapy Lecture schedule.

11

Information

Microsoft Word - 2.Syllabus PHR185P 2011 18 September2011.doc

11 pages

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

12333


You might also be interested in

BETA
KP99130Swimmono
WESTERGREN
Microsoft Word - 2.Syllabus PHR185P 2011 18 September2011.doc
Hoarding
Microsoft Word - studentroles_C&I.doc